Maravai counsel awarded 776 shares at $2.84
Maravai LifeSciences Holdings, Inc. reported that General Counsel Kurt Oreshack acquired 776 shares of Class A Common Stock at $2.84 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Maravai LifeSciences Holdings, Inc. reported that General Counsel Kurt Oreshack acquired 776 shares of Class A Common Stock at $2.84 per share. These shares were obtained through the company’s 2020 Employee Stock Purchase Plan and the transaction was exempt under Rule 16b-3.
Following this grant/award acquisition, Oreshack directly holds a total of 385,767 shares of Class A Common Stock. This is a routine compensation-related purchase rather than an open-market buy or sale.
Insider Trade Summary
Grant/Award: 776 shares
Grant/Award
1 txn
Insider
ORESHACK KURT
Role
General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 776 | $2.84 | $2K |
Holdings After Transaction:
Class A Common Stock — 385,767 shares (Direct)
Footnotes (1)
- F1. The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 776 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.
Key Figures
Shares acquired: 776 shares
Acquisition price: $2.84 per share
Total holdings after transaction: 385,767 shares
+1 more
4 metrics
Shares acquired
776 shares
Class A Common Stock grant/award acquisition
Acquisition price
$2.84 per share
Price under 2020 Employee Stock Purchase Plan
Total holdings after transaction
385,767 shares
Direct ownership following ESPP acquisition
Acquire transactions in filing
1 transaction
Form 4 transaction summary acquireCount
Key Terms
Employee Stock Purchase Plan, Rule 16b-3, Class A Common Stock, Form 4
4 terms
Employee Stock Purchase Plan financial
"pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3 regulatory
"The acquisition of those 776 shares of Class A Common Stock was exempt pursuant to Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Class A Common Stock financial
"acquisition of shares of the Issuer's Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Maravai Lifesciences (MRVI) report for Kurt Oreshack?
Maravai Lifesciences reported that General Counsel Kurt Oreshack acquired 776 shares of Class A Common Stock. The shares were obtained through the 2020 Employee Stock Purchase Plan as a routine compensation-related transaction exempt under Rule 16b-3, rather than an open-market purchase or sale.
Was the Maravai Lifesciences (MRVI) insider transaction under a compensation or trading plan?
The reported insider transaction was made under Maravai’s 2020 Employee Stock Purchase Plan. This indicates a compensation-related share acquisition, not an open-market trading decision, and the filing notes the transaction was exempt from certain rules under Rule 16b-3.
What does Rule 16b-3 exemption mean for the Maravai Lifesciences (MRVI) insider trade?
The Rule 16b-3 exemption means the 776-share acquisition is treated as a compensatory transaction approved under SEC rules. Such grants or purchases under company plans typically avoid short-swing profit rules, distinguishing them from discretionary open-market trades by insiders.
AI-generated analysis. How Rhea-AI works. Not financial advice.
